Acrylamide applied during pregnancy causes the neurotoxic effect by lowering bdnf levels in thefetal brain

dc.contributor.authorErdemli, Mehmet Erman
dc.contributor.authorAladag, M. Arif
dc.contributor.authorAltinoz, Eyup
dc.contributor.authorDemirtas, Sezin
dc.contributor.authorTurkoz, Yusuf
dc.contributor.authorYigitcan, Birgul
dc.contributor.authorBag, Harika Gozukara
dc.date.accessioned2019-07-04T11:27:03Z
dc.date.available2019-07-04T11:27:03Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjectives: The aim of this study is to elucidate the possible mechanism of neurotoxic effect of acrylamide (AA) applied during pregnancy on fetal brain development and to show the effect of N-acetylcysteine (NAC) on AA toxicity. Materials and methods: Four groups were formed with 9 pregnant rats each as control (C), acrylamide (AA), N-acetylcysteine (NAC), acrylamide plus N-acetylcysteine (AA plus NAC) groups. Caesarian section was implemented on the 20th day of pregnancy. Malondialdehyde (MDA), reduced glutathione (GSH), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), catalase (CAT) and Brain-derived neurotrophic factor (BDNF) levels were analyzed and histopathologic examinations were performed in brain tissues of the fetuses. Results: Our data indicated that AA caused necrotic death and hemorrhagic damages in fetal brain tissue with decreasing BNDF levels and increasing oxidative stress. N-acetylcysteine prevented the toxic effects of its on fetal brain (p < 0.05). Conclusion: Our study indicated that acrylamide has toxic effects in the fetal brain and N-acetylcysteine prevents its toxic effect.en_US
dc.identifier.citationErdemli, ME . Aladag, MA. Altinoz, E. Demirtas, S. Turkoz, Y. Yigitcan, B . Bag, HG. (2018). Acrylamide applied during pregnancy causes the neurotoxic effect by lowering bdnf levels in thefetal brain. Cilt:67. 37-43 ss.en_US
dc.identifier.doi10.1016/j.ntt.2018.03.005en_US
dc.identifier.endpage43en_US
dc.identifier.startpage37en_US
dc.identifier.urihttps://hdl.handle.net/11616/12340
dc.identifier.volume67en_US
dc.language.isoenen_US
dc.publisherPergamon-elsevıer scıence ltd, the boulevard, langford lane, kıdlıngton, oxford ox5 1gb, englanden_US
dc.relation.ispartofNeurotoxıcology and teratologyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectN-acetylcysteıneen_US
dc.subjectneurotrophıc factoren_US
dc.subjectdıetary-tınakeen_US
dc.subjectraten_US
dc.subjectfooden_US
dc.subjectsupplementatıonen_US
dc.subjectneuroprotectıonen_US
dc.subjectneurogenesıshıppen_US
dc.subjectocampusen_US
dc.subjectcarcınogenen_US
dc.titleAcrylamide applied during pregnancy causes the neurotoxic effect by lowering bdnf levels in thefetal brainen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
makale dosyası.pdf
Boyut:
2.46 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale dosyası
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: